- Home
- CRVO vs XTNT Comparison
CRVO vs XTNT Comparison
Compare CRVO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- XTNT
- Stock Information
- Founded
- CRVO 2001
- XTNT N/A
- Country
- CRVO United States
- XTNT United States
- Employees
- CRVO N/A
- XTNT N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRVO Health Care
- XTNT Health Care
- Exchange
- CRVO Nasdaq
- XTNT Nasdaq
- Market Cap
- CRVO 98.3M
- XTNT 83.2M
- IPO Year
- CRVO N/A
- XTNT N/A
- Fundamental
- Price
- CRVO $2.28
- XTNT $0.59
- Analyst Decision
- CRVO Buy
- XTNT Strong Buy
- Analyst Count
- CRVO 8
- XTNT 1
- Target Price
- CRVO $33.00
- XTNT $3.00
- AVG Volume (30 Days)
- CRVO 98.9K
- XTNT 50.3K
- Earning Date
- CRVO 03-31-2025
- XTNT 03-31-2025
- Dividend Yield
- CRVO N/A
- XTNT N/A
- EPS Growth
- CRVO N/A
- XTNT N/A
- EPS
- CRVO N/A
- XTNT N/A
- Revenue
- CRVO $10,066,550.00
- XTNT $113,862,000.00
- Revenue This Year
- CRVO $34.17
- XTNT $31.27
- Revenue Next Year
- CRVO N/A
- XTNT $13.07
- P/E Ratio
- CRVO N/A
- XTNT N/A
- Revenue Growth
- CRVO 116.29
- XTNT 45.11
- 52 Week Low
- CRVO $1.80
- XTNT $0.33
- 52 Week High
- CRVO $26.38
- XTNT $1.30
- Technical
- Relative Strength Index (RSI)
- CRVO 41.42
- XTNT 52.36
- Support Level
- CRVO $2.14
- XTNT $0.55
- Resistance Level
- CRVO $2.37
- XTNT $0.62
- Average True Range (ATR)
- CRVO 0.14
- XTNT 0.05
- MACD
- CRVO 0.09
- XTNT -0.01
- Stochastic Oscillator
- CRVO 56.41
- XTNT 41.76
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.